Evidence map›Paper›PMID 35530873›Full record

ReviewCureus2022

Nail Cancer: Review of the Two Main Types of an Underestimated Disease.

Camilo Levi Acuña Pinzon, Jefferson Fabian Nieves Condoy, Daniel A Rivera Marquez, Alan Ramón Javier Collazo Moreno, Roland Kevin Cethorth Fonseca, Luis Abraham Zúñiga Vázquez

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Differential diagnosis of pigmented nail lesions.Anais brasileiros de dermatologia
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Camilo Levi Acuña PinzonSurgery, Hospital Regional de Alta Especialidad del Bajío, León, MEX.
Jefferson Fabian Nieves CondoySurgery, Hospital Regional de Alta Especialidad del Bajío, León, MEX.
Daniel A Rivera MarquezSurgery, Hospital Regional de Alta Especialidad del Bajío, León, MEX.
Alan Ramón Javier Collazo MorenoSurgery, Hospital Regional de Alta Especialidad del Bajío, León, MEX.
Roland Kevin Cethorth FonsecaGeneral Surgery, Hospital Regional de Alta Especialidad del Bajío, León, MEX.
Luis Abraham Zúñiga VázquezSurgical Oncology, Hospital Regional De Alta Especialidad Del Bajío, León, MEX.
Hospital Regional de Alta Especialidad del Bajío · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neoplastic lesions (benign or malignant) in the nail region are rare when compared to lesions in the rest of the skin. Despite advances in diagnostic modalities, their diagnosis is frequently delayed or overlooked for days, months, or even years when they are misrecognized or when their approach is not appropriate. Undoubtedly, malignant tumors are the most important lesions since an inopportune diagnosis or treatment can drastically change the patient's prognosis. A review of all the scientific evidence on the two main malignant neoplasms of the nail apparatus (melanoma and squamous cell carcinoma) was carried out using the PubMed search engine from 2003 to 2022, in order to expose the appropriate diagnostic approach and treatment of these nail lesions to avoid delays that obscure the prognosis of patients. This review does not include reconstruction modalities after lesion resection, but the emphasis is placed on the great functional impact they produce. Surgical treatment in the early stages is the most important when talking about prognosis and emphasizing it; systemic oncological management of advanced stages is not so deep.

Indexed as

malignant tumorsmalignant tumors of nailmelanomanail apparatusnail cancernail diseasesquamous cell carcinoma

Identifiers

PMID35530873
PMCPMC9072075
OpenAlexW4225371914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.